PARADIGM-HF Trial and its Important Clinical Meanings
نویسنده
چکیده
ACEi/ARB and ß blocker and aldosterone antagonist have been a gold standard for treating chronic heart failure with reduced ejection fraction (HFrEF). The paper described simply the PARADIGM-HF study (Prospective comparison of ARNi with ACEi to Determine Impact on Global Mortality and morbidity in HF trial), and the results showed that compared to enalapril, LCZ69(ARNi) significantly reduced the primary endpoint (cardiovascular death or hospitalization for HF) [HR0.80 (95% CI 0.73-0.87),P<0.001; NNT 21], cardiovascular death [HR0.80 (95% CI 0.71-0.89),P<0.001; NNT 31], hospitalization for HF [HR0.79 (95% CI 0.71-0.89),P<0.001; NNT 36], and death from any cause [HR0.84 (95% CI 0.76-0.93), P<0.001; NNT 36]. LCZ696 was well tolerated. The PARADIGM-HF study has an important clinical significance and would change the pattern of HF treatment in the future.
منابع مشابه
Critical Questions about PARADIGM-HF and the Future.
Cardiovascular (CV) diseases in general and heart failure (HF) in particular are major contributors to death and morbidity and are also recognized as important drivers of health care expenditure. The PARADIGM-HF trial was a pivotal trial designed to compare the long-term effects of LCZ696 with enalapril in patients with symptomatic HF with reduced ejection fraction (HFrEF). This review article ...
متن کاملFactors Associated With Noncompletion During the Run-In Period Before Randomization and Influence on the Estimated Benefit of LCZ696 in the PARADIGM-HF Trial
Although randomized controlled trials represent the “gold standard” for assessment of comparative efficacy, there are frequent concerns about the generalizability of the results to the broader population of patients seen in clinical practice. In the Prospective Comparison of ARNI With an AngiotensinConverting Enzyme Inhibitor to Determine Impact on Global Mortality and Morbidity in Heart Failur...
متن کاملThe effect of peer education on quality of life in heart failure patients: A randomized clinical trial
Background and Purpose: Heart failure (HF) is a chronic, debilitating disease, and physical limitations and progressive symptoms of which associated with this condition can reduce quality of life (QOL). Patient education regarding heart HF is one of the main components of self-care. In this respect, peer education is significant in improving health and creating a learning environment. This stud...
متن کاملThe Impact of a Web-based Family-oriented Supportive Education Program in Adherence to Treatment of The Heart Failure Patients after Discharge from Hospital; A Randomized Clinical Trial
Background and purpose: Patient adherence to treatment is considered as an important aspect of treatment. Inadequate adherence to treatment of the heart failure (HF) patients leads to intensification of the disease, high risk of re-hospitalization and death. In this respect, this study was designed and implemented with the aim to determine the effect of a Web-based family-oriented supportive ed...
متن کاملDrug therapy for patients with systolic heart failure after the PARADIGM-HF trial: in need of a new paradigm of LCZ696 implementation in clinical practice
Heart failure represents a primary cause of morbidity and mortality in older people and despite significant therapeutic advances, it is still characterized by important unmet needs, thus remaining a challenging field of clinical research. The recent PARADIGM-HF trial compared the novel compound LCZ696, a combination of the angiotensin receptor blocker valsartan and the neprilysin inhibitor sacu...
متن کامل